Zepbound (tirzepatide) is a glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist that is FDA-approved along with increased physical activity and a reduced-calorie diet for chronic weight management in adults with a starting body mass index (BMI) of: 30 kg/m^2 or higher (obesity) or 27 kg/m^2 or higher (overweight) with at least one weight-related condition such as high cholesterol, high blood pressure (hypertension), type 2 diabetes, heart disease, or obstructive sleep apnea
Research on semaglutide (Ozempic, Wegovy) during breastfeeding is limited
However, because there is no routine surveillance of peptide use in Australia, we dont yet know which peptides are most commonly used or how patterns of use are changing over time
In contrast, for a newer tattoo featuring bright, bold colors, our laser technicians must adjust the lasers settings to target each hue, a factor that can add time to your treatment plan
If a product has not been FDA-approved for a specific condition, it cannot be promoted as safe or effective for that condition